SG11201502890PA - Method of isolating synagis® in the absence of benzonase - Google Patents
Method of isolating synagis® in the absence of benzonaseInfo
- Publication number
- SG11201502890PA SG11201502890PA SG11201502890PA SG11201502890PA SG11201502890PA SG 11201502890P A SG11201502890P A SG 11201502890PA SG 11201502890P A SG11201502890P A SG 11201502890PA SG 11201502890P A SG11201502890P A SG 11201502890PA SG 11201502890P A SG11201502890P A SG 11201502890PA
- Authority
- SG
- Singapore
- Prior art keywords
- benzonase
- absence
- isolating synagis
- synagis
- isolating
- Prior art date
Links
- 108010034546 Serratia marcescens nuclease Proteins 0.000 title 1
- 229940036185 synagis Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261722590P | 2012-11-05 | 2012-11-05 | |
PCT/US2013/068403 WO2014071344A2 (en) | 2012-11-05 | 2013-11-05 | Method of isolating synagis® in the absence of benzonase |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201502890PA true SG11201502890PA (en) | 2015-06-29 |
Family
ID=50628269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201502890PA SG11201502890PA (en) | 2012-11-05 | 2013-11-05 | Method of isolating synagis® in the absence of benzonase |
Country Status (12)
Country | Link |
---|---|
US (1) | US20150284447A1 (en) |
EP (1) | EP2914617A4 (en) |
JP (1) | JP2015533854A (en) |
KR (1) | KR20150084836A (en) |
CN (1) | CN104854125A (en) |
AU (1) | AU2013337346A1 (en) |
BR (1) | BR112015009969A2 (en) |
CA (1) | CA2890339A1 (en) |
MX (1) | MX2015005579A (en) |
RU (1) | RU2015121410A (en) |
SG (1) | SG11201502890PA (en) |
WO (1) | WO2014071344A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
CN107108054B (en) | 2014-10-31 | 2020-10-13 | 免疫医疗有限责任公司 | Improved manufacturing method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5118796A (en) * | 1987-12-09 | 1992-06-02 | Centocor, Incorporated | Efficient large-scale purification of immunoglobulins and derivatives |
US7786273B2 (en) * | 2005-03-14 | 2010-08-31 | Medimmune, Llc | Macromolecules comprising a thioether cross-link |
WO2008087184A2 (en) * | 2007-01-17 | 2008-07-24 | Merck Serono S.A. | Process for the purification of fc-containing proteins |
AU2008209404B2 (en) * | 2007-01-22 | 2012-08-16 | Genentech, Inc. | Polyelectrolyte precipitation and purification of antibodies |
CN104974251A (en) * | 2008-10-20 | 2015-10-14 | Abbvie公司 | Viral inactivation during purification of antibodies |
WO2012078376A1 (en) * | 2010-12-08 | 2012-06-14 | Amgen Inc. | Ion exchange chromatography in the presence of an amino acid |
-
2013
- 2013-11-05 KR KR1020157012227A patent/KR20150084836A/en not_active Application Discontinuation
- 2013-11-05 WO PCT/US2013/068403 patent/WO2014071344A2/en active Application Filing
- 2013-11-05 JP JP2015540855A patent/JP2015533854A/en active Pending
- 2013-11-05 RU RU2015121410A patent/RU2015121410A/en not_active Application Discontinuation
- 2013-11-05 US US14/440,640 patent/US20150284447A1/en not_active Abandoned
- 2013-11-05 BR BR112015009969A patent/BR112015009969A2/en not_active IP Right Cessation
- 2013-11-05 MX MX2015005579A patent/MX2015005579A/en unknown
- 2013-11-05 SG SG11201502890PA patent/SG11201502890PA/en unknown
- 2013-11-05 EP EP13850948.4A patent/EP2914617A4/en not_active Withdrawn
- 2013-11-05 CA CA2890339A patent/CA2890339A1/en not_active Abandoned
- 2013-11-05 CN CN201380057815.7A patent/CN104854125A/en active Pending
- 2013-11-05 AU AU2013337346A patent/AU2013337346A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2015533854A (en) | 2015-11-26 |
CN104854125A (en) | 2015-08-19 |
EP2914617A4 (en) | 2016-05-25 |
WO2014071344A8 (en) | 2015-05-28 |
AU2013337346A1 (en) | 2015-05-14 |
EP2914617A2 (en) | 2015-09-09 |
CA2890339A1 (en) | 2014-05-08 |
BR112015009969A2 (en) | 2017-07-11 |
RU2015121410A (en) | 2016-12-27 |
MX2015005579A (en) | 2016-01-25 |
WO2014071344A3 (en) | 2014-08-28 |
KR20150084836A (en) | 2015-07-22 |
US20150284447A1 (en) | 2015-10-08 |
WO2014071344A2 (en) | 2014-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2884394A4 (en) | Administration system and administration method | |
ZA201500037B (en) | Abutment system and detal methods | |
HUE042300T2 (en) | Additional effect system and method for multi-projection | |
EP2881138A4 (en) | Infusion set and method for using same | |
GB201117278D0 (en) | Method and system | |
ZA201309700B (en) | Electrodesalination system and method | |
EP2874680A4 (en) | Pump system and method | |
HK1216683A1 (en) | Systems and methods for integrated application platforms | |
SG11201502550YA (en) | Connection system and method | |
EP2897009A4 (en) | Production-sequence-optimizing method and production-sequence-optimizing system | |
GB201208548D0 (en) | Compound and method | |
GB201219800D0 (en) | System and method | |
EP2875348A4 (en) | Method for the isolation of microvesicles | |
SG11201408326TA (en) | Preparation method for perfluoro-2-methyl-3-pentanone and intermediate | |
PL2920647T3 (en) | Additional effect system and method for multi-projection | |
EP2868742A4 (en) | Filtering member and filtering method | |
GB201221234D0 (en) | Method and system estimating the size of a joined table | |
EP2800494A4 (en) | Fastening system and method | |
IL236154A0 (en) | Compound and method | |
GB2521236B (en) | Pool systems and methods for making and using same | |
EP2837624A4 (en) | 4-substituent-2-hydroxylmorpholine-3-one and preparation method thereof | |
SG11201500474PA (en) | Nutriculture member and nutriculture method | |
SG11201502890PA (en) | Method of isolating synagis® in the absence of benzonase | |
EP2853555A4 (en) | Film and preparation method thereof | |
GB2524634B (en) | Glazing system and methods |